SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK) -- Ignore unavailable to you. Want to Upgrade?


To: mopgcw who wrote (522)10/19/2003 10:11:24 AM
From: Biotech Jim  Read Replies (2) | Respond to of 598
 
"T792 is an oral agent that acts through the central nervous system to effect weight loss"

Any additional news or insight into this and its mechanism of action? Was wondering if this might be an MCHR antagonist?

BJ